|
|
||||||||
J Thorac Cardiovasc Surg 1999;117:488-495
© 1999 Mosby, Inc.
SURGERY FOR CONGENITAL HEART DISEASE |
From Helsinki University Central Hospital, Hospital for Children and Adolescents, Helsinki, Finland.
Received for publication March 19, 1998. Revisions requested June 1, 1998. Revisions received Sept 8, 1998. Accepted for publication Sept 10, 1998. Address for reprints: Mikko Kirjavainen, MD, Helsinki University Central Hospital, Hospital for Children and Adolescents, PL 281, Helsinki 00029 HYKS, Finland.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Between 1978 and 1991, 133 patients with TGA, including other cardiac anomalies, underwent the Senning operation in one single hospital in Finland. After that era, the Senning operation has been performed in only a few cases. The early results were published in 1985.
7 We report the long-term results of the first 100 patients with either simple TGA or TGA and ventricular septal defect (VSD).
The purpose of our study was to determine the incidence of late death, sinus node dysfunction (SND), and RVD and to compare incidence of these late complications in patients who have TGA with or without VSD. We also evaluated risk factors for late death.
| Patients and methods |
|---|
|
|
|---|
Patient characteristics
Between October 1978 and August 1988, 100 patients with TGA or with TGA and VSD underwent the Senning operation in Helsinki University Children's Hospital. The patients were classified to the simple group if the interventricular septum was intact (simple, n = 73) or to the complex group if there was a coexisting VSD (complex, n = 27; Table I). Patients with multiple associated cardiac anomalies, such as double-outlet right ventricle and coarctation of the aorta, were excluded. The operations were performed by 3 surgeons. Mean age at operation was 6.9 months, and there was a tendency over time to operate at an earlier age with the age at operation decreasing from 12 months to 4 months.
|
Surgical technique
The surgical technique was as described by Senning.
1 The suture line in the vicinity of the sinus node was placed close to the superior vena caval orifice in an attempt to avoid direct damage to the sinus node. All operations were performed with the patient in deep hypothermia (18°C-25°C). The perioperative variables are summarized in Table II. The bypass time, aortic crossclamp time, and time of total circulatory arrest shortened considerably over time.
|
Statistics
Survival analysis for late death, rhythm disturbances, and RVD were performed by the Kaplan-Meier method. The log-rank test was used to estimate the difference between the 2 groups. Cox proportional hazard regressions were used to assess risk factors for late death. Variables likely to affect survival were entered in a univariate analysis (Table III). To identify independent predictors of late death, a multifactorial stepwise Cox proportional hazard regression analysis with SND and RVD entered as time-dependent co-variables was performed. Statistical software used were StatView (Version 4.51; Abacus Concepts, Berkeley, Calif) and S-Plus (Version 4.5; MathSoft, Inc, Seattle, Wash).
|
| Results |
|---|
|
|
|---|
Reoperation
Four reoperations were performed on 3 patients. Pneumonectomy was required in 1 patient in the simple group because of total occlusion of the pulmonary veins and recurrent pneumonia 6 years after the Senning operation. In the simple group, there was 1 reoperation in 73 patients, and in the complex group there were 3 reoperations in 25 patients. One patient had severe TR 5 years after the Senning operation. She underwent valvuloplasty with a later tricuspid valve replacement. Another patient in the complex group had severe heart failure 9 years after the operation and underwent heart transplantation.
Late deaths
There were 8 late deaths, 4 in the simple group and 4 in the complex group. In the simple group, 4 patients died 7.5 years (mean) after the Senning operation (range, 3-13 years). One of these patients died of a noncardiac cause. Two patients died suddenly. They both had mild to moderate RVD. One of them had atrial flutter, and the other was in stable sinus rhythm. The fourth patient in the simple group died of cerebral abscess. He had no RVD, but mild SND.
In the complex group, 4 patients died 6.6 years (mean) after the Senning operation (range, 3 months15 years). There were 2 sudden deaths. The third patient died of pulmonary hypertension and right ventricular failure 3 months after the Senning operation. The fourth patient had severe TR and progressively worsening RVD 1 year after the operation. He also had severe SND and a pacemaker. No autopsy was done.
In multivariate analysis of the risk of late death with RVD and SND included as time-dependent covariables RVD (hazard ratio, 11.4; 95% confidence intervals [CI], 2.8 and 46.9) and arrhythmias (hazard ratio, 5.1; 95% CI, 1.1 and 22.8) emerged as independent risk factors.
The overall survival for the patients having the Senning operation was 90%. In the simple group the survival was 97%, and in the complex group the survival was 78%. On the other hand, the probability of survival after 16 years of follow-up was 90% (95% CI, 0.89 and 1.00) in the simple group and 70% (95% CI, 0.48 and 0.93) in the complex group. The difference between groups was statistically significant (P = .01; Fig. 1).
|
|
|
Fifteen patients (21%) in the simple group and 9 patients (36%) in the complex group required pacemaker implantation. The indications for pacemaker implantations were SND with severe bradycardia in 68%, CAVB in 16%, and SND with arrhythmia and antiarrhythmic treatment in 16%. The mean time of implantations was 8.3 years after the Senning operation.
Right ventricular function and TR
RVD was a late problem in our study. RVD was diagnosed at a mean interval of 10.3 years after the Senning operation. At the end of the follow-up, 82% of the patients in the simple group and 62% of the patients in the complex group had normal systemic ventricular function. The incidence of moderate or severe RVD was higher in the complex group (Fig 4). All patients with significant RVD were treated with an angiotensin-converting enzyme inhibitor (enalapril) alone or combined with digoxin. Still, 75% of patients with RVD had no symptoms.
|
|
Significant TR was found in 5 patients (7%) in the simple group and in 4 (16%) patients in the complex group. One patient with severe TR underwent valvuloplasty with a later tricuspid valve replacement. Another patient with moderate TR and severe RVD underwent successful heart transplantation. Two other patients died suddenly with RVD. TR was detected with echocardiography at an average of 7.5 years after the Senning operation. Forty-six percent of patients in the simple group and 52% of patients in the complex group had mild or physiologic TR. All patients who had clinically important TR were treated with enalapril.
Other late cardiac problems
Two patients in both groups (simple [3%] and complex [8%]) had dynamic left ventricular outflow tract obstruction. Mild mitral valve regurgitation was found in 1 patient in both groups. They both also had TR. Six years after the operation, 1 patient had complete left pulmonary vein obstruction and recurrent pneumonia. He underwent pneumonectomy. Another patient in the simple group had slight narrowing of the venous pathway with increased flow velocity at Doppler echocardiography, but with clinically normal venous pressure.
Functional status
At final follow-up, 86% of the patients in the simple and 83% of the patients in the complex group were in New York Heart Association (NYHA) class I. The remainder of the patients in the simple group were in class II. One patient in the complex group was in class III (5%).
Neurologic problems
Neurologic problems were found in 13 patients, 10 patients in the simple group (14%) and 3 patients in the complex group (14%). Four patients had absence episodes clinically resembling partial epilepsy; 5 patients had delay in psychomotor development; 3 patients had learning disabilities; and 1 patient had a mild hemiplegia. Problems cumulated in patients who underwent the operation earlier during this series. Eleven of 13 patients with neurologic problems underwent the operation before 1982. The mean age at the time of the Senning operation was over 12 months in these patients. Five patients had the same symptoms before the operation. Three of the patients had preoperative cerebral infarction.
| Discussion |
|---|
|
|
|---|
It is obvious that SND is not inherent to the basic disease but secondary to the surgical interventions.
12,13 Postulated mechanisms for SND include disruption of sinus node arterial flow and direct iatrogenic damage to the sinus node and atrial muscle. Extensive suture lines in the atria favor the re-entry mechanism.
10,12,13 The incidence of moderate or severe SND was higher in the complex group. The proportion of patients in sinus rhythm decreased progressively. The probability of sinus rhythm after 17 years of follow-up was 31% with patients in the simple group and 7% with patients in the complex group. SND became more frequent with time, but it could not be established as a risk factor for late death. These findings have also been established by others.
10,14 Most patients with SND did not experience important limitations in daily activities.
The loss of sinus rhythm and the appearance of tachyarrhythmias in patients with atrial switch repair are well documented in many Mustard studies.
11,15,16 The incidence of symptomatic tachyarrhythmias has varied between 5% and 15%. Atrial flutter has been found ominous, especially with RVD, and its appearance increases the risk of sudden death 4-fold after the Mustard operation. In addition, the appearance of atrial flutter seems to be an early sign of decreasing right ventricular function.
11 Our results support these earlier findings, showing a hazard ratio of 5.1 for late death in patients with active arrhythmias. The incidence of sudden death in patients with atrial switch repair has varied between 2% and 9%.
16 In our study, the incidence of sudden cardiac death was 4%.
There were 24 pacemaker implantations (24%) in our study. The number is high compared with other long-term follow-up studies.
3,4,6,10 We implanted a pacemaker if the patient had significant bradycardia or long pauses (over 3 seconds) or if the patient already had documented atrial flutter necessitating treatment with antiarrhythmic drugs. Pacing the heart at normal physiologic rates with AAI or DDD modes is hoped to retard ventricular dilation and thus maintain better systemic ventricular function. Also, keeping the atrial pacing rates high enough helps to avoid atrial flutter associated with bradycardia. Pacing does not seem to prevent sudden cardiac death after atrial switch, which most often seems to be secondary to an atrial tachyarrhythmia with 1:1 conduction.
17
Postoperative systemic ventricular function is a major concern after atrial repair of TGA. It is not as common as rhythm disturbances, but it has a great clinical importance. In our study, RVD was an independent risk factor for late death with a hazard ratio of 11.4. We estimated right ventricular function using echocardiography. Despite its limitations, it may be the best method available for clinical work at the moment.
18-20 Several factors contribute to RVD: SND with bradycardia, TR, preoperative hypoxia, and perioperative factors.
20,21 In addition, the ability of the right ventricle to perform efficiently in the systemic position has been questioned for anatomic reasons.
21,22
In many studies RVD was detected at the end of the follow-up. Mee
23 estimated the incidence of RVD at 10% or more after the first 10 years. In our study, the incidence of RVD was 8% for patients with simple TGA and 26% for patients with complex TGA. Twenty-five percent of the patients had symptoms. Unfortunately, the incidence of RVD increased progressively after 10 years. The probability of maintaining normal systemic ventricular function 16 years after the Senning operation was only 52% in the simple group and 39% in the complex group. With angiographic studies, one could probably detect an even greater amount of patients with impaired right ventricular function. In the study by Rubay and associates,
24 only 44% of patients had an ejection fraction higher than 0.50 and an end-diastolic volume not exceeding 80 mL x m2 after 4 years (mean) of follow-up. In addition, in the study by Bender and associates,
9 already 60% of patients had an abnormal response to exercise after 3 years of follow-up. On the other hand 97.5% of them were in NYHA class I.
Maintaining adequate systemic ventricular function is paramount for long-term survival after atrial switch operations for TGA. Afterload-reducing medical therapy with angiotensin-converting enzyme inhibitors has been shown to be beneficial in long-term follow-up of patients with left ventricular dysfunction.
25-27 This seems to be true even if the patients are free of symptoms. It is probable that the aggressive use of afterload reduction could also delay the deterioration of systemic ventricular function in patients who have undergone a Senning operation, although there are no published reports on the subject. Our group has used enalapril, an angiotensin-converting enzyme inhibitor, either alone or together with digoxin, in all patients showing significant RVD or moderate to severe TR.
At the moment there are not many surgical methods to deal with RVD. Tricuspid valve valvuloplasty or replacement can be considered if there is significant TR and the right ventricular function is reasonably good. Late staged conversion to arterial switch has been proposed in the face of RVD. However, the mortality rate of this procedure has been high.
21 Our group has elected not to pursue late arterial switch as a management option. Heart transplantation is the remaining possibility with end-stage heart failure. So far, 1 patient in our series has undergone heart transplantation.
Operative deaths for the Senning operation have been low (1% to 9%).
3,22,28-30 In our study there were no primary deaths in the simple group. Two patients in the complex group died within 12 hours after operation. Midterm survival has also been excellent with 90% to 95% of children surviving 10 years.
9 In our study the overall mortality rate, including perioperative deaths, for 12.8 years (mean) of follow-up was 10%. There was 1 noncardiac death. The probability of surviving 16 years was 94% in the simple group and 70% in the complex group. One half of the late deaths were sudden. RVD and active arrhythmias constituted risk factors for late death. However, SND alone did not emerge as a risk factor.
VSD with TGA forms a group of its own. Both the morbidity and mortality rates of the Senning procedure for complex TGA have been high. George and associates
30 reported a 3-fold late mortality rate, compared with the patients with simple TGA, a result similar to our series. In short-term results, the main difference in our study was that there were 2 early deaths (7.4%) in the complex group versus no early death in the simple group. The incidence of postoperative CAVB was 5.2-fold in the patients with complex TGA; they also received twice as many pacemakers. During follow-up, patients with complex TGA had twice as much RVD, with moderate and severe RVD cumulating in the complex group. The higher incidence of these late problems, especially RVD, in the complex group may be due to iatrogenic damage to the tricuspid valve as a result of VSD closure. Organic damage to the tricuspid valve may also result from the presence of the VSD itself.
23
Despite SND and RVD, most of our patients had a good functional status. Most of the patients were in New York Heart Association class I or II. The presence of SND had little influence on the patients' functional classification, unless they also had active atrial arrhythmias or bradycardia necessitating pacemaker implantation. On the other hand, our findings show that RVD after the Senning operation is a late phenomenon necessitating close follow-up through adulthood. It seems probable that, with time, increasing numbers of patients with atrial switch procedures will need heart transplantations.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
P. Khairy, L. Harris, M. J. Landzberg, S. M. Fernandes, A. Barlow, L.-A. Mercier, S. Viswanathan, P. Chetaille, E. Gordon, A. Dore, et al. Sudden Death and Defibrillators in Transposition of the Great Arteries With Intra-atrial Baffles: A Multicenter Study Circ Arrhythmia Electrophysiol, October 1, 2008; 1(4): 250 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Horer, E. Karl, G. Theodoratou, C. Schreiber, J. Cleuziou, Z. Prodan, M. Vogt, and R. Lange Incidence and results of reoperations following the Senning operation: 27 years of follow-up in 314 patients at a single center Eur. J. Cardiothorac. Surg., June 1, 2008; 33(6): 1061 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lange, J. Horer, M. Kostolny, J. Cleuziou, M. Vogt, R. Busch, K. Holper, H. Meisner, J. Hess, and C. Schreiber Presence of a Ventricular Septal Defect and the Mustard Operation Are Risk Factors for Late Mortality After the Atrial Switch Operation: Thirty Years of Follow-Up in 417 Patients at a Single Center Circulation, October 31, 2006; 114(18): 1905 - 1913. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Dos, L Teruel, I J Ferreira, J Rodriguez-Larrea, L Miro, J Girona, D C Albert, A Goncalves, M Murtra, and J Casaldaliga Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries Heart, May 1, 2005; 91(5): 652 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dodge-Khatami, A. Kadner, F. Berger, H. Dave, M. I. Turina, and R. Pretre In the Footsteps of Senning: Lessons Learned From Atrial Repair of Transposition of the Great Arteries Ann. Thorac. Surg., April 1, 2005; 79(4): 1433 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Poirier, J.-H. Yu, C. P. Brizard, and R. B. B. Mee Long-term results of left ventricular reconditioning and anatomic correction for systemic right ventricular dysfunction after atrial switch procedures J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 975 - 981. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Moons, M Gewillig, T Sluysmans, H Verhaaren, P Viart, M Massin, B Suys, W Budts, A Pasquet, D De Wolf, et al. Long term outcome up to 30 years after the Mustard or Senning operation: a nationwide multicentre study in Belgium Heart, March 1, 2004; 90(3): 307 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Williams, B. W. McCrindle, D. A. Ashburn, R. A. Jonas, C. Mavroudis, E. H. Blackstone, and the members of the Congenital Heart Surgeon's Soci Outcomes of 829 neonates with complete transposition of the great arteries 12-17 years after repair Eur. J. Cardiothorac. Surg., July 1, 2003; 24(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Hovels-Gurich, M.-C. Seghaye, Q. Ma, M. Miskova, R. Minkenberg, B. J. Messmer, and G. von Bernuth Long-term results of cardiac and general health status in children after neonatal arterial switch operation Ann. Thorac. Surg., March 1, 2003; 75(3): 935 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Devaney, J. R. Charpie, R. G. Ohye, and E. L. Bove Combined arterial switch and Senning operation for congenitally corrected transposition of the great arteries: Patient selection and intermediate results J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 500 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ando, B. W. Duncan, and R. B.B. Mee Anatomic correction for corrected transposition after pulmonary unifocalization Ann. Thorac. Surg., March 1, 2003; 75(3): 1012 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K.F. Hon, P. Steendijk, M. Petrou, K. Wong, and M. H. Yacoub Influence of clenbuterol treatment during six weeks of chronic right ventricular pressure overload as studied with pressure-volume analysis J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 767 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Losay, A. Touchot, A. Serraf, A. Litvinova, V. Lambert, J. D. Piot, F. Lacour-Gayet, A. Capderou, and C. Planche Late Outcome After Arterial Switch Operation for Transposition of the Great Arteries Circulation, September 18, 2001; 104(90001): I-121 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Nieminen, E. V. Jokinen, and H. I. Sairanen Late Results of Pediatric Cardiac Surgery in Finland: A Population-Based Study With 96% Follow-Up Circulation, July 31, 2001; 104(5): 570 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Amin, D. B. McElhinney, P. Moore, V. M. Reddy, and F. L. Hanley Coronary arterial size late after the atrial inversion procedure for transposition of the great arteries: Implications for the arterial switch operation J. Thorac. Cardiovasc. Surg., December 1, 2000; 120(6): 1047 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kreutzer, J. De Vive, G. Oppido, J. Kreutzer, K. Gauvreau, M. Freed, J. E. Mayer Jr, R. Jonas, and P. J. del Nido Twenty-five-year experience with Rastelli repair for transposition of the great arteries J. Thorac. Cardiovasc. Surg., August 1, 2000; 120(2): 211 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mavroudis and C. L. Backer Arterial switch after failed atrial baffle procedures for transposition of the great arteries Ann. Thorac. Surg., March 1, 2000; 69(3): 851 - 857. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |